anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
atai Life Sciences · pitchdeck

ATAI | Investor Presentation Deck | 36 slides

36 pages · 4 arc beats · 2 loops

Pitchdeck Download JSON
Unlock

ATAI | Investor Presentation Deck | 36 slides

atai Life Sciences · 2022-09
arc beats above · slides in the middle · loops below · scroll → 2 LOOPS
SETUP TENSION ANALYSIS EVIDENCE RESOLUTION APPENDIX
HOVER FOR DETAILS · CLICK A SLIDE FOR FULLSCREEN · STEP 2
— No image bound to this slide. Wire up imgproxy to display the rendered slide JPEG.
—

Deck intelligence map

4
coverage by narrative range · generated from this deck JSON
Narrative range 4 total
Metadata
Components
Metrics
Tools
Frameworks
Beats
Loops
Problem 1 slides 100% 1/1 slides 100% 1/1 slides · 10 hits
— 0/1 slides
100% 1/1 slides 100% 1/1 slides 100% 1/1 slides 100% 1/1 slides Solution 1 slides 100% 1/1 slides 100% 1/1 slides · 7 hits
— 0/1 slides
100% 1/1 slides
— 0/1 slides
100% 1/1 slides 100% 1/1 slides Market Size 1 slides 100% 1/1 slides 100% 1/1 slides · 12 hits
— 0/1 slides
— 0/1 slides
— 0/1 slides
100% 1/1 slides
— 0/1 slides
Team 1 slides 100% 1/1 slides 100% 1/1 slides · 8 hits
— 0/1 slides
— 0/1 slides
— 0/1 slides
100% 1/1 slides
— 0/1 slides

Slide inventory

36
every slide · same image gating as the playbook
01
Slide 1
front_matter
Open slide detail
02
Includes a specific date note at the bottom: September 9th, 2022.other
Open slide detail
03
The slide uses a numbered list to present key company highlights.summarize
Open slide detail
04
The slide uses a combination of headshots for the team and a metric-based footer to establish credibility.other
Open slide detailBeat · Team
05
The slide uses a hierarchical structure to connect a high-level objective to three distinct operational pillars.present_solution
Open slide detailBeat · SolutionLoop · Quick Win Big Bet
06
The slide uses a Gantt-style visualization to show progress through Preclinical, Phase 1, and Phase 2 stages for multiple assets.plan_implementation
Open slide detailLoop · Quick Win Big Bet
07
The slide uses a hub-and-spoke diagram to represent the platform model.present_solution
Open slide detailLoop · Quick Win Big Bet
08
The slide uses a horizontal arrow timeline for future catalysts and a vertical list for past milestones.plan_implementation
Open slide detailLoop · Quick Win Big Bet
09
Slide 09 of the deck.summarize
Open slide detail
10
The slide uses a minimalist design with a portrait of a person to evoke an emotional connection to the topic.transition
Open slide detail
11
Uses a split-layout: left side provides market context/sizing, right side provides clinical pain points.frame_problem
Open slide detailBeat · ProblemLoop · Cost Of Inaction
12
The slide uses a line chart to demonstrate clinical efficacy over 12 weeks compared to baseline.show_traction
Open slide detailLoop · Cost Of Inaction
13
The slide combines a product summary table on the left with a clinical trial line chart on the right.summarize
Open slide detail
14
The slide uses a split-layout with a dark sidebar for summary metrics and a white main area for clinical data visualization.summarize
Open slide detail
15
The slide uses chemical structures and bar charts to demonstrate the superiority of R-ketamine over S-ketamine.compare_peers
Open slide detail
16
CADSS = Clinician Administered Dissociative States Scale. Data points represent individual patient scores over time.analyze_data
Open slide detail
17
The slide outlines a clinical trial protocol for a drug candidate (PCN-101) targeting Treatment-Resistant Depression (TRD).plan_implementation
Open slide detail
18
The slide uses a feature-comparison matrix to highlight differentiation in mechanism, duration, and distribution.compare_peers
Open slide detail
19
transition
Open slide detail
20
The slide uses a combination of a problem overview, a global impact section, and a 'huge need' vertical timeline/list.frame_problem
Open slide detail
21
The slide uses a vertical timeline/process flow to demonstrate the de-risking of the drug candidate from pre-clinical to Phase 2a.show_traction
Open slide detail
22
Includes a quote from Keith Nuechterlein and a detailed clinical trial timeline.summarize
Open slide detail
23
The slide highlights efficacy in cognitive endpoints for a specific patient population (DPNP).show_traction
Open slide detail
24
CIAS likely refers to Cognitive Impairment Associated with Schizophrenia.show_traction
Open slide detail
25
The slide uses a checkmark system to highlight specific advantages of RL-007 and a few competitors.compare_peers
Open slide detail
26
transition
Open slide detail
27
The slide uses a split-layout: left side defines the problem and market size, right side details the unaddressed need.size_opportunity
Open slide detailBeat · Market Size
28
Includes a sidebar summary and a clinical trial design overview.summarize
Open slide detail
29
The table uses checkmarks to indicate the presence of favorable attributes across different drug classes.compare_peers
Open slide detail
30
transition
Open slide detail
31
Uses a combination of a map, big numbers, and a vertical process-style list to convey market urgency.size_opportunity
Open slide detail
32
Includes a summary table on the left and a clinical trial roadmap/process diagram on the bottom right.summarize
Open slide detail
33
The table highlights DMX-1002's unique profile compared to withdrawal support and maintenance therapies.compare_peers
Open slide detail
34
transition
Open slide detail
35
The slide uses a card-based layout to detail the value proposition and operational structure of four distinct entities.present_solution
Open slide detail
36
inspire_vision
Open slide detail